Evidence map›Paper›PMID 23300552›Full record

ArticlePloS one2012

APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis.

Duncan B Johnstone, Vijay Shegokar, Deepak Nihalani, Yogendra Singh Rathore, Leena Mallik, Ashish, Vasant Zare, H Omer Ikizler, Rajaram Powar, Lawrence B Holzman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 85 citations in OpenAlex.

  1. Update on APOL1 and chronic kidney diseases in children.Pediatric nephrology (Berlin, Germany) · 2026
    Review
  2. Article
  3. Kidney medicine · 2025
    Review
  4. Article
  5. Review
  6. Mechanisms of podocyte injury in genetic kidney disease.Pediatric nephrology (Berlin, Germany) · 2025
    Review
  7. Multiethnic prevalence of theClinical kidney journal · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Novel Therapies inKidney international reports · 2023
    Review
  16. Obstetric medicine · 2022
    Article
  17. Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Duncan B JohnstoneRenal-Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA, USA. Duncan.Johnstone@tuhs.temple.edu
Vijay Shegokar
Deepak Nihalani
Yogendra Singh Rathore
Leena Mallik
Ashish
Vasant Zare
H Omer Ikizler
Rajaram Powar
Lawrence B Holzman
Government Medical College · INInstitute of Microbial Technology · INUniversity of Pennsylvania · USCouncil of Scientific and Industrial Research · INNagpur Institute of Technology · INTemple University Health System · US

Funding

Myo1c Participates in Podocyte Junction Formation Through Interaction with Neph1R01DK087956 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI NIHALANI, DEEPAK · 2010 to 2018
$3.5M
NIDDK NIH HHS K08-DK081626NIDDK NIH HHS R01 1R01DK087956NIDDK NIH HHS R01 DK087956
6 · The paper itself

Abstract

backgroundAmong African-Americans, genome wide association revealed a strong correlation between the G1 and G2 alleles of APOL1 (apolipoproteinL1, also called trypanolytic factor) and kidney diseases including focal and segmental glomerulosclerosis, HIV-associated nephropathy and hypertensive nephrosclerosis. In the prevailing hypothesis, heterozygous APOL1 G1 and G2 alleles increase resistance against Trypanosoma that cause African sleeping sickness, resulting in positive selection of these alleles, but when homozygous the G1 and G2 alleles predispose to glomerulosclerosis. While efforts are underway to screen patients for G1 and G2 alleles and to better understand "APOL1 glomerulopathy," no data prove that these APOL1 sequence variants cause glomerulosclerosis. G1 and G2 correlate best with glomerulosclerosis as recessive alleles, which suggests a loss of function mutation for which proof of causality is commonly tested with homozygous null alleles. This test cannot be performed in rodents as the APOL gene cluster evolved only in primates. However, there is a homozygous APOL1 null human being who lives in a village in rural India. This individual and his family offer a unique opportunity to test causality between APOL1 null alleles and glomerulosclerosis. METHODS AND

findingsWe obtained clinical data, blood and urine from this APOL1 null patient and 50 related villagers. Based on measurements of blood pressure, BUN, creatinine, albuminuria, genotyping and immunoblotting, this APOL1 null individual does not have glomerulosclerosis, nor do his relatives who carry APOL1 null alleles.

conclusionsThis small study cannot provide definitive conclusions but the absence of glomerulosclerosis in this unique population is consistent with the possibility that African-American glomerulosclerosis is caused, not by loss of APOL1 function, but by other mechanisms including a subtle gain of function or by the "genetic hitchhiking" of deleterious mutations in a gene linked to APOL1 G1 and G2.

Indexed as

AdultAgedAged, 80 and overAllelesFemaleGlomerulosclerosis, Focal SegmentalHeterozygoteHomozygoteHumansIndiaMaleMiddle AgedMutationRisk FactorsRural PopulationYoung Adult

Identifiers

PMID23300552
PMCPMC3530541
OpenAlexW2142295376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.